Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO CLINICAL BREAKTHROUGHS IN GASTROENTEROLOGY

April 2021

GASTROENTEROLOGY

MILLER RECEIVES BIOMATERIALS AWARD FOR CELIAC DISEASE NANOPARTICLE THERAPY


​Featuring: Stephen Miller, PhD

​Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology, has received the 2021 Technology Innovation and Development Award from the Society For Biomaterials (SFB).

Miller is among a group of scientists who designed and tested nanoparticles that induce gluten tolerance in celiac disease, findings that were published in the journal Gastroenterology.

“The study is the first demonstration that immune tolerance to gluten can be induced in humans with celiac using a ‘negative vaccine’ consisting of gluten encapsulated within nanoparticles which induces a regulatory immune response,” said Miller, who is also a professor of Dermatology, of Medicine in the Division of Gastroenterology and Hepatology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

About 1 percent of the population has celiac disease, a serious autoimmune disease in which the ingestion of gluten leads to damage in the small intestine. When people with celiac disease eat gluten — a protein found in wheat — their body mounts an immune response that attacks the small intestine.

Miller and his colleagues designed a biodegradable nanoparticle containing gluten that teaches the immune system that gluten is safe. The nanoparticle acts like a Trojan horse, hiding the allergen in a friendly shell to convince the immune system not to attack it.

​After treatment with the technology, patients in the trial were able to eat gluten with a substantial reduction in inflammation, while patients in the untreated control group developed inflammation in the small intestine that is a characteristic of celiac disease.

Currently, there is no treatment for celiac disease, and doctors can only recommend gluten avoidance. This nanoparticle platform could be the key to a long-awaited treatment, not just for celiac disease but for other autoimmune and allergic diseases as well, according to Miller.

“Traditional treatments for autoimmune disease employ immunosuppressive drugs which lack specificity and make patients highly susceptible to infections and increase rates of cancer,” Miller said. “The clinical trial proved that the gluten-containing nanoparticles were safe and highly efficacious.”

The study was sponsored by COUR Pharmaceuticals Development and supported by Takeda Pharmaceuticals International.

The SFB is a multidisciplinary society of academic, healthcare, governmental and business professionals dedicated to promoting advancements in all aspects of biomaterial science, education and professional standards to enhance human health and quality of life.

This article was originally published in the Feinberg School of Medicine News Center on April 12, 2021. 
Stephen Miller, PhD headshot
Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology, received the 2021 Technology Innovation and Development Award from the Society For Biomaterials (SFB).

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM Gastroenterologist

You May Also Like

Swallowing graphic

October 2020

GASTROENTEROLOGY
Wireless Monitoring Informs Acid Reflux Therapy
Headshots of Bethany Doerfler and Dr. John Pandolfino

January 2020

GASTROENTEROLOGY
Treating GERD with Dietary Therapy
Video still of Bethany Doerfler

December 2019

GASTROENTEROLOGY
Food-Related Quality of Life in Patients with IBD & IBS

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties